| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0B | $5.0B | $5.1B | $5.2B | $5.8B | $1.4B | $1.2B | $1.2B |
| Cost of Revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.2B | $1.0B | $0.9B |
| Gross Profit | $3.9B | $3.9B | $3.9B | $4.0B | $4.6B | $1.1B | $1.0B | $1.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $1.9B | $1.9B | $1.8B | $2.0B | $2.1B | $1.9B | $2.0B |
| Operating Income | $0.5B | $0.4B | $0.4B | $0.5B | $0.7B | $0.6B | $0.6B | $0.7B |
| Net Income | $0.2B | $0.3B | $0.1B | $0.3B | $0.4B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $2.22 | $2.53 | $1.44 | $3.26 | $4.22 | $0.61 | $0.41 | $0.36 |
| EPS (Diluted) | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $0.59 | $0.40 | $0.34 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.8B | $2.7B | $2.8B | $2.7B | $2.8B | $3.1B | $2.7B | $2.8B |
| Current Assets | $1.1B | $1.1B | $1.4B | $1.4B | $1.4B | $1.8B | $1.5B | $1.8B |
| Cash & Equivalents | $0.4B | $0.4B | $0.6B | $0.5B | $0.6B | $1.0B | $0.8B | $1.2B |
| Total Liabilities | $3.3B | $3.5B | $3.9B | $4.0B | $4.2B | $3.9B | $3.1B | $3.5B |
| Current Liabilities | $1.0B | $1.2B | $1.3B | $1.0B | $1.1B | $1.1B | $1.0B | $1.6B |
| Stockholders' Equity | $-0.5B | $-0.8B | $-1.1B | $-1.3B | $-1.4B | $-0.9B | $-0.4B | $-0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B | $0.5B | $0.6B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $-0.2B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.3B | $-0.1B | $-0.3B | $-0.7B | $-0.3B | $-0.7B | $-0.6B |